Thomas Tu - Dec 27, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Medical Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Stock symbol
NARI
Transactions as of
Dec 27, 2022
Transactions value $
-$628,302
Form type
4
Date filed
12/28/2022, 03:32 PM
Previous filing
Nov 30, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $4.57K +10K +11.57% $0.46* 96.5K Dec 27, 2022 Direct F1
transaction NARI Common Stock Sale -$410K -6.53K -6.77% $62.75 89.9K Dec 27, 2022 Direct F1, F2
transaction NARI Common Stock Sale -$120K -1.87K -2.08% $63.88 88.1K Dec 27, 2022 Direct F1, F3
transaction NARI Common Stock Sale -$90.5K -1.4K -1.59% $64.66 86.7K Dec 27, 2022 Direct F1, F4
transaction NARI Common Stock Sale -$13.1K -200 -0.23% $65.67 86.5K Dec 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $0 -10K -5.9% $0.00 160K Dec 27, 2022 Common Stock 10K $0.46 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $62.39 to $63.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $63.39 to $64.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $64.43 to $64.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.